Victory Capital Management
ANIP icon

Victory Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Victory Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Sell
40,018
-60,547
-60% -$4.86M ﹤0.01% 1489
2026
Q1 		$7.73M Buy
100,565
+19,450
+24% +$1.52M 0.01% 1168
2025
Q4 		$6.4M Buy
81,115
+16,971
+26% +$1.47M ﹤0.01% 1223
2025
Q3 		$5.88M Sell
64,144
-15,560
-20% -$1.27M ﹤0.01% 1287
2025
Q2 		$5.2M Buy
79,704
+62,841
+373% +$4.09M ﹤0.01% 1310
2025
Q1 		$1.13M Buy
16,863
+3,086
+22% +$184K ﹤0.01% 1747
2024
Q4 		$762K Buy
13,777
+858
+7% +$49.3K ﹤0.01% 1916
2024
Q3 		$771K Buy
12,919
+7,825
+154% +$477K ﹤0.01% 1880
2024
Q2 		$324K Sell
5,094
-1,735
-25% -$113K ﹤0.01% 2079
2024
Q1 		$472K Buy
+6,829
New +$412K ﹤0.01% 2001
2022
Q4 		– Sell
-19,665
Closed -$632K – 2592
2022
Q3 		$632K Sell
19,665
-359
-2% -$12.3K ﹤0.01% 1943
2022
Q2 		$594K Buy
20,024
+840
+4% +$24.2K ﹤0.01% 1972
2022
Q1 		$566K Sell
19,184
-5,945
-24% -$222K ﹤0.01% 2080
2021
Q4 		$1.16M Sell
25,129
-2,994
-11% -$129K ﹤0.01% 1777
2021
Q3 		$923K Sell
28,123
-4,177
-13% -$130K ﹤0.01% 1902
2021
Q2 		$1.13M Sell
32,300
-25,493
-44% -$867K ﹤0.01% 1849
2021
Q1 		$2.09M Buy
+57,793
New +$1.81M ﹤0.01% 1640
2020
Q2 		– Sell
-12,667
Closed -$516K – 2536
2020
Q1 		$516K Sell
12,667
-2,516
-17% -$134K ﹤0.01% 1829
2019
Q4 		$936K Buy
15,183
+6,652
+78% +$441K ﹤0.01% 1773
2019
Q3 		$622K Buy
8,531
+6,792
+391% +$508K ﹤0.01% 1815
2019
Q2 		$143K Sell
1,739
-3,023
-63% -$215K ﹤0.01% 1497
2019
Q1 		$336K Buy
+4,762
New +$280K ﹤0.01% 1419
2017
Q3 		– Sell
-1,905
Closed -$89K – 1810
2017
Q2 		$89K Buy
1,905
+284
+18% +$13.7K ﹤0.01% 1693
2017
Q1 		$80K Buy
1,621
+615
+61% +$34.5K ﹤0.01% 1686
2016
Q4 		$61K Sell
1,006
-25
-2% -$1.53K ﹤0.01% 1685
2016
Q3 		$68K Buy
+1,031
New +$64.5K ﹤0.01% 1656

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's ANIP Position: Q2 2026 in Review

Victory Capital Management reduced its ANI Pharmaceuticals (ANIP) stake by 60% in Q2 2026, selling an estimated $4.86M and leaving 40,018 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Victory Capital Management first reported a position in ANIP in Q3 2016 and has held it in 26 quarters since. The position peaked at $7.73M in Q1 2026. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Victory Capital Management held 40,018 shares of ANI Pharmaceuticals worth $3.31M as of Q2 2026.
  • Victory Capital Management sold 60,547 ANI Pharmaceuticals shares in Q2 2026, an estimated $4.86M.
  • ANI Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1489 holding.
  • Victory Capital Management first reported a position in ANI Pharmaceuticals in Q3 2016 and has held it in 26 quarters since.
  • Victory Capital Management's ANI Pharmaceuticals position peaked at $7.73M in Q1 2026.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.